Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists
Hesketh, P.J., Van Belle, S., Aapro, M., Tattersall, F.D., Naylor, R.J., Hargreaves, R., Carides, A.D., Evans, J.K., Horgan, K.J.
Published in European journal of cancer (1990) (01.05.2003)
Published in European journal of cancer (1990) (01.05.2003)
Get full text
Journal Article
Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind Phase III trial in patients undergoing open abdominal surgery
Diemunsch, P., Gan, T.J., Philip, B.K., Girao, M.J., Eberhart, L., Irwin, M.G., Pueyo, J., Chelly, J.E., Carides, A.D., Reiss, T., Evans, J.K., Lawson, F.C.
Published in British journal of anaesthesia : BJA (01.08.2007)
Published in British journal of anaesthesia : BJA (01.08.2007)
Get full text
Journal Article
Addition of the Oral NK1 Antagonist Aprepitant to Standard Antiemetics Provides Protection Against Nausea and Vomiting During Multiple Cycles of Cisplatin-Based Chemotherapy
DE WIT, R, HERRSTEDT, J, RAPOPORT, B, CARIDES, A. D, CARIDES, G, ELMER, M, SCHMIDT, C, EVANS, J. K, HORGAN, K. J
Published in Journal of clinical oncology (15.11.2003)
Published in Journal of clinical oncology (15.11.2003)
Get full text
Journal Article
The oral NK1 antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials
de Wit, R., Herrstedt, J., Rapoport, B., Carides, A.D., Guoguang-Ma, J., Elmer, M., Schmidt, C., Evans, J.K., Horgan, K.J.
Published in European journal of cancer (1990) (01.02.2004)
Published in European journal of cancer (1990) (01.02.2004)
Get full text
Journal Article
Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis
Cocquyt, V, Van Belle, S, Reinhardt, R.R, Decramer, M.L.A, O'Brien, M, Schellens, J.H.M, Borms, M, Verbeke, L, Van Aelst, F, De Smet, M, Carides, A.D, Eldridge, K, Gertz, B.J
Published in European journal of cancer (1990) (01.05.2001)
Published in European journal of cancer (1990) (01.05.2001)
Get full text
Journal Article
Prevention of Cisplatin-Induced Emesis by the Oral Neurokinin-1 Antagonist, MK-869, in Combination With Granisetron and Dexamethasone or With Dexamethasone Alone
CAMPOS, Daniel, RODRIGUES PEREIRA, Jose, CARIDES, Alexandra D, GERTZ, Barry J, REINHARDT, Rick R, CARRACEDO, Carlos, POLI, Sergio, VOGEL, Conrado, MARTINEZ-CEDILLO, Jorge, ERAZO, Aura, WITTREICH, Johanna, ERIKSSON, Lars-Olof
Published in Journal of clinical oncology (15.03.2001)
Published in Journal of clinical oncology (15.03.2001)
Get full text
Journal Article
Functional relevance of antiemetic control: experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant
Martin, A.R, Carides, A.D, Pearson, J.D, Horgan, K, Elmer, M, Schmidt, C, Cai, B, Chawla, S.P, Grunberg, S.M
Published in European journal of cancer (1990) (01.07.2003)
Published in European journal of cancer (1990) (01.07.2003)
Get full text
Journal Article
A Phase 3, randomized, double-blind study of single-dose fosaprepitant for prevention of cisplatin-induced nausea and vomiting: Results of an Indian population subanalysis
Maru, A, Gangadharan, V, Desai, C, Mohapatra, R, Carides, A
Published in Indian journal of cancer (01.10.2013)
Published in Indian journal of cancer (01.10.2013)
Get full text
Journal Article
Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response
Hesketh, P. J., Grunberg, S. M., Herrstedt, J., de Wit, R., Gralla, R. J., Carides, A. D., Taylor, A., Evans, J. K., Horgan, K. J.
Published in Supportive care in cancer (01.04.2006)
Published in Supportive care in cancer (01.04.2006)
Get full text
Journal Article
Simultaneous investigation of indinavir nonlinear pharmacokinetics and bioavailability in healthy volunteers using stable isotope labeling technique: Study design and model‐independent data analysis
Yeh, Kuang C., Stone, Julie A., Carides, Alexandra D., Rolan, Paul, Woolf, Eric, Ju, William D.
Published in Journal of pharmaceutical sciences (01.05.1999)
Published in Journal of pharmaceutical sciences (01.05.1999)
Get full text
Journal Article
Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia
Shahinfar, Shahnaz, Simpson, Roger L., Carides, Alexandra D., Thiyagarajan, Balasamy, Nakagawa, Yasushi, Umans, Jason G., Parks, Joan H., Coe, Fredric L., for the Losartan Uric Acid Study Group
Published in Kidney international (01.11.1999)
Published in Kidney international (01.11.1999)
Get full text
Journal Article
Effect of aprepitant on antiemetic protection in patients receiving moderately emetogenic chemotherapy plus high-dose cisplatin: Analysis of combined data from 2 phase III randomized clinical trials
Gralla, R. J., Warr, D. G., Carides, A. D., Evans, J. K., Horgan, K. J.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Pharmacokinetics of Rizatriptan Tablets During and Between Migraine Attacks
Cutler, Neal R., Jhee, Stanford S., Majumdar, Anup K., McLaughlin, Debra, Brucker, Mary Jo, Carides, Alexandra D., Kramer, Mark S., Matzura-Wolfe, Deborah, Reines, Scott A., Goldberg, Michael R.
Published in Headache (01.04.1999)
Published in Headache (01.04.1999)
Get full text
Journal Article
Detection Bias Due to the Effect of Finasteride on Prostate Volume: A Modeling Approach for Analysis of the Prostate Cancer Prevention Trial
Cohen, Yael C., Liu, Kenneth S., Heyden, Norman L., Carides, Alexandra D., Anderson, Keaven M., Daifotis, Anastasia G., Gann, Peter H.
Published in JNCI : Journal of the National Cancer Institute (19.09.2007)
Published in JNCI : Journal of the National Cancer Institute (19.09.2007)
Get full text
Journal Article
Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting: Results from a randomized, double-blind, placebo-controlled trial in latin america
POLI-BIGELLI, Sergio, RODRIGUES-PEREIRA, Jose, CARIDES, Alexandra D, MA, Guoguang Julie, ELDRIDGE, Krista, HIPPLE, Anita, EVANS, Judith K, HORGAN, Kevin J, LAWSON, Francesca
Published in Cancer (15.06.2003)
Published in Cancer (15.06.2003)
Get full text
Journal Article
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
HESKETH, Paul J, GRUNBERG, Steven M, EVANS, Judith K, BECK, Klaus, REINES, Scott, HORGAN, Kevin J, GRALLA, Richard J, WARR, David G, ROILA, Fausto, DE WIT, Ronald, CHAWLA, Sant P, CARIDES, Alexandra D, LANUS, Juliana, ELMER, Mary E
Published in Journal of clinical oncology (15.11.2003)
Published in Journal of clinical oncology (15.11.2003)
Get full text
Journal Article
The oral NK1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials
Warr, David G., Grunberg, Steven M., Gralla, Richard J., Hesketh, Paul J., Roila, Fausto, Wit, Ronald de, Carides, Alexandra D., Taylor, Arlene, Evans, Judith K., Horgan, Kevin J.
Published in European journal of cancer (1990) (01.06.2005)
Published in European journal of cancer (1990) (01.06.2005)
Get full text
Journal Article
Effect of aprepitant on antiemetic protection in patients receiving moderately emetogenic chemotherapy plus high-dose cisplatin: Analysis of combined data from 2 phase III randomized clinical trials
Gralla, R. J., Warr, D. G., Carides, A. D., Evans, J. K., Horgan, K. J.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article